Skip to content

Nutrition in Pediatric Oncology in Central America

The Role of a Nutritional Program on Delivery of Nutritional Services and Cost of Care in Children With Cancer in Central America

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03976830
Enrollment
126
Registered
2019-06-06
Start date
2019-01-01
Completion date
2021-10-01
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutrition in Cancer Survival and Treatment

Keywords

Malnutrition, Childhood Cancer, Central America

Brief summary

This study investigates nutritional status, at predefined points in therapy, and the association with outcomes in children and adolescents undergoing treatment for cancer in institutions under Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA) consortium in Central America. The aim of the study is to examine the effects of the newly-established nutritional program aimed at improving the delivery of nutritional care and outcomes in children undergoing treatment for cancer in Central America.

Detailed description

In low and middle-income countries, children with cancer are simultaneously dealing with malnutrition in high proportions. Without proper access to care and a minimal or basic level of care, these children are exposed to worse conditions. Studies have shown that more than half of the children with cancer are also malnourished at diagnosis. This increases children's risk of complications associated with the treatment as well as the abandonment of care, as well as decrease the level of survival rates. With an established nutritional education and clinical intervention program, the outcomes of these children can be improved, especially in Central America where the cancer rates and malnutrition is high, as shown by several studies.

Interventions

None listed

Sponsors

Hospital Escuela Universitario, Honduras
CollaboratorUNKNOWN
Columbia University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of childhood cancer (Solid tumors, Acute Lymphoblastic Leukemia (ALL), other Lymphomas) * Recruited at diagnosis * Under the age of 18 years

Exclusion criteria

* Other cancer diagnosis * Palliative care patients

Design outcomes

Primary

MeasureTime frameDescription
Rate of malnutrition3 yearsDetermine the change in malnutrition by comparing nutritional status measured by anthropometric data at diagnosis and during and end of treatment.
Rate of utilization of nutritional interventions3 yearsImpact on the delivery of nutritional services, defined as utilization of nutritional interventions. Information on utilization of nutritional services will be collected on a medical nutrition support (MNS) case report form, which collects information on the provision of enteral feeds (nasogastric feeds, gastrostomy feeds), oral nutrition supplements (e.g. Pediasure®, Ensure®) and days of total parenteral nutrition (TPN) over the previous phase of treatment. The MNS form also provides information on the brand of nutritional formula and the prescribed dose (i.e. amount in grams of supplement per day). If enteral feeds are administered, the formula, rate, and duration are reported. The responses collected on the MNS form will be used to determine the rate of utilization of nutritional interventions.

Secondary

MeasureTime frameDescription
Readmission rate3 yearsThe readmission rate will be measured by the number of readmissions.
Total duration of hospital stay3 yearsThe total duration of hospital stay will be measured in days.
Rate of chemotherapy dose reductions3 yearsThe rate of chemotherapy dose reductions will be measured.
Survival rate3 yearsSurvival is defined by both overall survival (time from enrollment to death from any cause) and event-free survival (time from enrollment to the first episode of relapse, disease progression or death).
Disease relapse rate3 yearsInvestigate the association of nutritional status and disease relapse
Cumulative number of grade 3/4 toxicities3 yearsInvestigate association of nutritional status and the occurrence of grade 3/4 toxicities using NCI Common Toxicity Criteria (CTC).
Number of treatment delays (in days)3 yearsThe number of treatment delays will be measured in days.

Countries

Honduras

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026